Rivoceranib Mesylate
Thông số
1218779-75-9Số CAS
881-162-7Số EC
N-[4-(1-cyanocyclopentyl)phenyl]-2-(pyridin-4-ylmethylamino)pyridine-3-carboxamide;methanesulfonic acidTên IUPAC
C25H27N5O4SCông thức hóa học
493.6 g/molKhối lượng phân tử
Apatinib; Apatinib Mesylate; 1218779-75-9; Rivoceranib mesylate; YN968D1; YN-968D1; TK02X14ASJ; DTXSID80153427; 3-Pyridinecarboxamide, N-(4-(1-cyanocyclopentyl)phenyl)-2-((4-pyridinylmethyl)amino)-, methanesulfonate (1:1); Aitan; 3-Pyridinecarboxamide, N-[4-(1-cyanocyclopentyl)phenyl]-2-[(4-pyridinylmethyl)amino]-, methanesulfonate (1:1); RefChem:930792; DTXCID8075918; 3-Pyridinecarboxamide, N-(4-(1-cyanocyclopentyl)phenyl)-2-((4-methyl-3-pyridinyl)amino)-; 881-162-7; N-(4-(1-cyanocyclopentyl)phenyl)-2-((pyridin-4-ylmethyl)amino)nicotinamide methanesulfonate; Rivoceranib mesylate (USAN); RIVOCERANIB MESYLATE [USAN]; N-[4-(1-cyanocyclopentyl)phenyl]-2-(pyridin-4-ylmethylamino)pyridine-3-carboxamide;methanesulfonic acid; YN 968D1; UNII-TK02X14ASJ; Apatinib Mesylate?; Alitan (TN); Apatinib (free base)?; MLS006011286; orb146156; orb320150; CHEMBL3545414; SCHEMBL21847695; GLXC-20747; HMS3655H12; HMS5087F06; Apatinib (registered name in China); MFCD22420814; RIVOCERANIB MESYLATE [WHO-DD]; AKOS026750547; CCG-269641; CS-0694; SB16589; N-(4-(1-Cyanocyclopentyl)phenyl)-2-((pyridin-4-ylmethyl)amino)nicotinamide Mesylate; AC-35390; DA-70982; FA145494; HY-13342; SMR004703036; SW220296-1; D11289; N-(4-(1-cyanocyclopentyl)phenyl)-2-(pyridin-4-ylmethylamino)nicotinamide mesylate; Methanesulfonic acid--N-[4-(1-cyanocyclopentyl)phenyl]-2-{[(pyridin-4-yl)methyl]amino}pyridine-3-carboxamide (1/1); N-[4-(1-cyanocyclopentyl)phenyl]-2-(4-pyridylmethylamino)pyridine-3-carboxamide;methanesulfonic acid; N-[4-(1-Cyanocyclopentyl)phenyl]-2-[(pyridin-4-ylmethyl)amino]pyridine-3-carboxamide monomethanesulfonate saltTên gọi khác